Future medicine: How to meet Europe’s disease challenges?

European citizens are living longer, gaining years, which they should spend with the highest quality of life. Europe needs a new approach to medicine fuelled by powerful technologies that will help people remain healthy throughout their lifetime. Not only do we have to change the way diseases are detected and treated, we also need to prepare for emerging health challenges. Digital and biomedical technologies have the capacity to potentiate other breakthroughs and transform medicine. Their integration promises to provide high-quality healthcare, strengthen Europe’s research and health industry, innovation capacity and global leadership. What are the steps that should be prioritised at a European level to boost this potential? Our high-level guests from politics, science, industry and the clinics will share their vision with you.
 

EVENT PROGRAMME

16:30 OPENING

Introduction – Today’s medical challenges, a perspective from oncology

Angelika Eggert, Director of the pediatric oncology and hematology department at the Charité-Universitätsmedizin Berlin

LifeTime vision  – Improving healthcare through cell-based interceptive medicine

Geneviève Almouzni, LifeTime coordinator, Institut Curie, CNRS

Horizon Europe – Quo vadis?

Anna Lönnroth Sjödén, Head of Unit – Healthy Lives, People Directorate Directorate-General for Research and Innovation, European Commission

Panel discussion – A lifetime impact: how to unleash the innovation potential of biomedical technologies?

• Christine Chomienne, Vice-Chair of the Mission Board Cancer at the European Commission
• Domenico De Martinis, Ministry of University and Research, Italy, Directorate-General for the coordination and valorisation of research and its results, OFFICE VIII Programming and promotion of international research and coordination of aerospace research
• Anna Lönnroth Sjödén, Head of Unit – Healthy Lives, People Directorate Directorate-General for Research and Innovation, European Commission
• Stefan Oelrich, Member of the Board of Management of Bayer AG, President Pharmaceuticals
• Aviv Regev, Co-chair Human Cell Atlas, Head of Genentech Research & Early Development
• Manfred Weber, Member of the European Parliament

Closing remarks – Next steps towards solutions for Europe

Nikolaus Rajewsky, LifeTime coordinator, Max Delbrück Center for Molecular Medicine in the Helmholtz Association

18:00 END

Moderator: Maryline Fiaschi, Managing Director Science|Business